These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21527584)

  • 1. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
    Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).
    Epeldegui M; Lee JY; Martínez AC; Widney DP; Magpantay LI; Regidor D; Mitsuyasu R; Sparano JA; Ambinder RF; Martínez-Maza O
    Clin Cancer Res; 2016 Jan; 22(2):328-36. PubMed ID: 26384320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma.
    Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O
    Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
    Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
    Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
    Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype.
    Breen EC; Boscardin WJ; Detels R; Jacobson LP; Smith MW; O'Brien SJ; Chmiel JS; Rinaldo CR; Lai S; Martínez-Maza O
    Clin Immunol; 2003 Nov; 109(2):119-29. PubMed ID: 14597210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.
    Guo Y; Siewe B; Epeldegui M; Detels R; Landay AL; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):204-10. PubMed ID: 23722608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
    Regidor DL; Detels R; Breen EC; Widney DP; Jacobson LP; Palella F; Rinaldo CR; Bream JH; Martínez-Maza O
    AIDS; 2011 Jan; 25(3):303-14. PubMed ID: 21192231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of microbial translocation and risk of AIDS-related lymphoma.
    Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
    AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
    Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
    [No Abstract]   [Full Text] [Related]  

  • 15. Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.
    De Roos AJ; Mirick DK; Edlefsen KL; LaCroix AZ; Kopecky KJ; Madeleine MM; Magpantay L; Martínez-Maza O
    Cancer Res; 2012 Sep; 72(18):4733-43. PubMed ID: 22846913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
    AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
    Landgren O; Goedert JJ; Rabkin CS; Wilson WH; Dunleavy K; Kyle RA; Katzmann JA; Rajkumar SV; Engels EA
    J Clin Oncol; 2010 Feb; 28(5):773-9. PubMed ID: 20048176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.
    Wong HL; Breen EC; Pfeiffer RM; Aissani B; Martinson JJ; Margolick JB; Kaslow RA; Jacobson LP; Ambinder RF; Chanock S; Martínez-Maza O; Rabkin CS
    AIDS; 2010 Apr; 24(7):1025-33. PubMed ID: 20299965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
    Purdue MP; Lan Q; Langseth H; Grimsrud TK; Hildesheim A; Rothman N
    Int J Cancer; 2020 Jun; 146(12):3312-3319. PubMed ID: 31523805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.